Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2022-06-13 00:00:00 ET · period of report 2022-06-09 · accession 0001567619-22-012778 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-13 | 2022-06-09 | RIGL | RODRIGUEZ RAUL R | CEO, Pres, Dir | P - Purchase | $0.69 | +1.00M | 1.39M | +255% | +$690.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-09 | P | A | 1,000,000 | $0.69 | 1,391,776 | D | — | — | (F1) The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $0.67 to $0.70. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price. |